Change search criteria ↓

Search results

22 projects found matching your search criteria:

  1. 1. Role of oxidative stress and ceramide in the pathogenesis of depression and in the mechanizm of action of antidepressant…

    Principal investigator: Justyna Józefa Brodowicz

    Instytut Farmakologii PAN

    Call: PRELUDIUM 12, Panel: NZ5

  2. 2. Evaluation of interactions of aripiprazole, the atypical amtipsychotic drug, with the selected antidepressants in the ra…

    Principal investigator: dr hab. Zofia Maria Rogóż

    Instytut Farmakologii PAN

    Call: OPUS 12, Panel: NZ7

  3. 3. The role of inflammation, oxidative and nitrosative stress, tryptophan catabolites pathway and DNA base excision repair …

    Principal investigator: dr hab. Tomasz Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 10, Panel: NZ7

  4. 4. Functional dissection of three alpha(1)-adrenergic receptor subtypes in the effects of antidepressant drugs: exploitatio…

    Principal investigator: prof. Irena Maria Nalepa

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  5. 5. The role of CRH-BP protein in the regulation of the hypothalamic-pituitary-adrenal axis after antidepressant drugs treat…

    Principal investigator: dr Joanna Solich

    Instytut Farmakologii PAN

    Call: OPUS 3, Panel: NZ4

  6. 6. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte…

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 23, Panel: NZ5

  7. 7. Research on influence of antidepressant drugs on serum and brain levels of neurotrophins in rats, affected by the time d…

    Principal investigator: dr Maciej Sławomir Kuśmider

    Instytut Farmakologii PAN

    Call: OPUS 4, Panel: NZ4

  8. 8. Role of the endocannabionoid system in the pathogenesis of depression and in the mechanism of action of antidepressant d…

    Principal investigator: prof. Małgorzata Maria Filip

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 3, Panel: NZ7

  9. 9. Dual Se-containing 5-HT1A and 5-HT7 biased agonists activating sigma-1 receptor as a hope of finding fast-acting antidep…

    Principal investigator: prof. Karolina Anna Pytka

    Uniwersytet Jagielloński

    Call: OPUS 27, Panel: NZ7

  10. 10. Modeling of quantitative structure-metabolic stability relationships as a tool to improve design of potential novel anti…

    Principal investigator: prof. Tomasz Bączek

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 12, Panel: NZ7

  11. 11. Role of the NLRP3 inflammasome in the mechanisms of action of antidepressant drugs - study in an animal model of depress…

    Principal investigator: dr Ewa Izabela Trojan

    Instytut Farmakologii PAN

    Call: PRELUDIUM 9, Panel: NZ7

  12. 12. Molecular mechanism of action of antidepressant drugs in the in vitro model of contact allergy in the human cell line Ha…

    Principal investigator: Katarzyna Curzytek

    Instytut Farmakologii PAN

    Call: PRELUDIUM 7, Panel: NZ6

  13. 13. The role of selected metabotropic glutamate receptors in the mechanism of rapid antidepressant effect of RS-ketamine and…

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

    Call: OPUS 14, Panel: NZ7

  14. 14. The effect of the metabotropic glutamatergic receptor ligands on potentiating the antidepressant-like actvity of scopola…

    Principal investigator: Karolina Sylwia Podkowa

    Instytut Farmakologii PAN

    Call: PRELUDIUM 10, Panel: NZ7

  15. 15. Research of mechanisms of antidepressant action of group II and III mGlu receptor ligands and their role in inducing rap…

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

    Call: OPUS 7, Panel: NZ7

  16. 16. The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants.

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: OPUS 5, Panel: NZ7

  17. 17. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 26, Panel: NZ7

  18. 18. The influence of microplastics on the toxicity and fate of selected antidepressants

    Principal investigator: prof. Grzegorz Leszek Nałęcz-Jawecki

    Warszawski Uniwersytet Medyczny

    Call: OPUS 18, Panel: NZ8

  19. 19. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ6

  20. 20. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 13, Panel: NZ7

  21. 21. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  22. 22. Electrochemical detection of phycotropic substances based on DNA intercalation

    Principal investigator: dr Joanna Maria Jankowska-Śliwińska

    Instytut Biocybernetyki i Inżynierii Biomedycznej im. Macieja Nałęcza PAN

    Call: PRELUDIUM 4, Panel: ST4

Graphic design and implementation: Jakub Piotrowski